Report cover image

U.S. Next-Generation Sequencing Library Preparation Market Size, Share, Trends, Industry Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End Use – Market Forecast, 2025–2034

Published Jul 01, 2025
Length 129 Pages
SKU # PLRS20324424

Description

The U.S. next-generation sequencing library preparation market size is expected to reach USD 2,167.71 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Next-Generation Sequencing Library Preparation Market Share, Size, Trends, Industry Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Next-generation sequencing library preparation is a crucial step in the sequencing workflow, involving the conversion of DNA or RNA samples into a format compatible with high-throughput sequencing platforms. The process includes fragmenting the nucleic acids, attaching specialized adapter sequences, and amplifying the material to generate a sequencing-ready library. The quality of library preparation directly impacts the accuracy and efficiency of sequencing.

Next-generation sequencing library preparation is widely used across genomics research, clinical diagnostics, and biotechnology. In whole-genome sequencing (WGS), it enables comprehensive analysis of an organism’s DNA, aiding in genetic variant detection and evolutionary studies.

U.S. Next-Generation Sequencing Library Preparation Market Report Highlights

In terms of sequencing type, the targeted genome sequencing segment accounted for 63.37% of revenue market share in 2024. Clinical researchers and diagnostic laboratories favored this approach due to its cost-effectiveness, high accuracy, and efficiency in identifying specific genetic variants associated with inherited diseases and cancers.

The whole genome sequencing segment, based on sequencing type, is projected to hold a substantial share in the coming years, owing to advancements in sequencing technologies and declining costs.

Based on product, the reagents & consumables segment dominated the market share in 2024 due to recurring demand for library preparation kits, enzymes, adapters, and amplification reagents used in every sequencing run.

In terms of application, the drug & biomarker discovery segment held the largest revenue share in 2024 due to the crucial role of next-generation sequencing library preparation in precision medicine and pharmaceutical research.

Based on end use, the academic and research institutions segment accounted for 37.83% of revenue market share in 2024 due to strong federal and private funding for genomics research and large-scale sequencing projects.

A few key players in the U.S. next-generation sequencing library preparation market include Agilent Technologies, Inc.; BD; F. Hoffmann-La Roche AG, Inc.; Illumina, Inc.; New England Biolabs Inc.; Oxford Nanopore Technologies; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Revvity, Inc.; Thermo Fisher Scientific Inc.; and Twist Bioscience.

Polaris Market Research has segmented the U.S. next-generation sequencing library preparation market report on the basis of sequencing type, product, application, and end use:

By Sequencing Type Outlook (Revenue, USD Million, 2020–2034)

Targeted Genome Sequencing

Whole Genome Sequencing

Whole Exome Sequencing

Other

By Product Outlook (Revenue, USD Million, 2020–2034)

Reagents & Consumables

DNA Library Preparation Kits

RNA Library Preparation Kits

Other

Instruments

By Application Outlook (Revenue, USD Million, 2020–2034)

Drug & Biomarker Discovery

Disease Diagnostics

Cancer Diagnostics

Reproductive Health Diagnostics

Infectious Disease Diagnostics

Other

Others

By End Use Outlook (Revenue, USD Million, 2020–2034)

Hospitals and Clinics

Academic and Research Institutions

Pharmaceutical and Biotechnology Companies

Others

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. U.S. Next-Generation Sequencing Library Preparation Market Insights
4.1. U.S. Next-Generation Sequencing Library Preparation Market – Market Snapshot
4.2. U.S. Next-Generation Sequencing Library Preparation Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technological Innovations Enhancing Library Preparation Processes
4.2.1.2. Expansion of Applications in Personalized Medicine and Drug Discovery
4.2.2. Restraints and Challenges
4.2.2.1. High Costs of Library Preparation Kits
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Next-Generation Sequencing Library Preparation Market Trends
4.6. Value Chain Analysis
5. U.S. Next-Generation Sequencing Library Preparation Market, by Sequencing Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by Sequencing Type, 2020-2034 (USD Million)
5.3. Targeted Genome Sequencing
5.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Targeted Genome Sequencing, by Region, 2020-2034 (USD Million)
5.4. Whole Genome Sequencing
5.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Whole Genome Sequencing, by Region, 2020-2034 (USD Million)
5.4.2. Whole Exome Sequencing
5.4.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by Whole Exome Sequencing, by Region, 2020-2034 (USD Million)
5.4.3. Others
5.4.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Others, by Region, 2020-2034 (USD Million)
6. U.S. Next-Generation Sequencing Library Preparation Market, by Product
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by Product, 2020-2034 (USD Million)
6.3. Reagents & Consumables
6.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Reagents & Consumables, by Region, 2020-2034 (USD Million)
6.3.2. DNA Library Preparation Kits
6.3.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by DNA Library Preparation Kits, by Region, 2020-2034 (USD Million)
6.3.3. RNA Library Preparation Kits
6.3.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by RNA Library Preparation Kits, by Region, 2020-2034 (USD Million)
6.3.4. Others
6.3.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Others, by Region, 2020-2034 (USD Million)
6.4. Instruments
6.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Instruments, by Region, 2020-2034 (USD Million)
7. U.S. Next-Generation Sequencing Library Preparation Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by Application, 2020-2034 (USD Million)
7.3. Drug & Biomarker Discovery
7.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Drug & Biomarker Discovery, by Region, 2020-2034 (USD Million)
7.4. Disease Diagnostics
7.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Disease Diagnostics, by Region, 2020-2034 (USD Million)
7.4.2. Cancer Diagnostics
7.4.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by Cancer Diagnostics, by Region, 2020-2034 (USD Million)
7.4.3. Reproductive Health Diagnostics
7.4.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Reproductive Health Diagnostics, by Region, 2020-2034 (USD Million)
7.4.4. Infectious Disease Diagnostics
7.4.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Infectious Disease Diagnostics, by Region, 2020-2034 (USD Million)
7.4.5. Others
7.4.5.1. U.S. Next-Generation Sequencing Library Preparation Market, by Others, by Region, 2020-2034 (USD Million)
7.5. Others
7.5.1. U.S. Next-Generation Sequencing Library Preparation Market, by Others, by Region, 2020-2034 (USD Million)
8. U.S. Next-Generation Sequencing Library Preparation Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Next-Generation Sequencing Library Preparation Market, by End Use, 2020-2034 (USD Million)
8.3. Hospitals and Clinics
8.3.1. U.S. Next-Generation Sequencing Library Preparation Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
8.4. Academic & Research Institutes
8.4.1. U.S. Next-Generation Sequencing Library Preparation Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Million)
8.5. Pharmaceutical and Biotechnology Companies
8.5.1. U.S. Next-Generation Sequencing Library Preparation Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Million)
8.6. Others
8.6.1. U.S. Next-Generation Sequencing Library Preparation Market, by Others, by Region, 2020-2034 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Agilent Technologies, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. BD
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. F. Hoffmann-La Roche AG, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Illumina, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. New England Biolabs Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Oxford Nanopore Technologies
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Pacific Biosciences of California, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. QIAGEN N.V.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Revvity, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Twist Bioscience
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.